For most patients, this means listing the diabetes diagnosis (E11.XX) as the primary code and the obesity diagnosis (E66.XX) as a secondary code
Hadidchi and her team are committed to supporting you at every step, helping you set realistic goals and answering any questions you may have about your progress or potential side effects
Anil Makam, M.D., an internal medicine physician at the University of California, San Francisco, notes that GLP-1s may be a future therapeutic option for people with substance use disorders
Ferdousie VT, Mohammadi MM, Hassanshahi G, Khorramdelazad H, Falahati-Pour SK, Mirzaei M, Tavakoli MA, Kamiab Z, Ahmadi Z, Vazirinejad R, Shahrabadi E, Koniari I, Kounis NG, Esmaeili Nadimi A